Financial Performance - Q3 2025 revenue reached $363.8 million, a 16% year-over-year increase[10, 12] - Center Margin for Q3 2025 was $116.6 million, representing 32.0% of revenue[10, 12] - Adjusted EBITDA for Q3 2025 was $40.2 million, or 11.1% of revenue[10, 12] Operational Metrics - Total clinicians increased to 7,996, an 11% year-over-year growth, with 288 net clinician additions in Q3[10, 12] - Q3 2025 visit volumes totaled 2.3 million, a 17% year-over-year increase[10] - The company ended Q3 with a cash position of $203.9 million[10] Guidance - The company reaffirmed its FY 2025 revenue guidance midpoint of $1.41 billion - $1.43 billion[20] - The company raised its FY 2025 Center Margin guidance from $441-$465 million to $448-$462 million[20] - The company raised its FY 2025 Adjusted EBITDA guidance from $140-$150 million to $146-$152 million[20]

Financial Performance - Q2 2025 revenue reached $345.3 million, an 11% year-over-year increase[9] - Q2 2025 Center Margin was $108.4 million, representing 31.4% of revenue[9] - Q2 2025 Adjusted EBITDA was $34.0 million, or 9.8% of revenue[9] - The company ended Q2 2025 with a cash position of $188.9 million[9] - Full year 2025 revenue guidance is reaffirmed at $1.40 billion - $1.44 billion[19] - Full year 2025 Adjusted EBITDA guidance is raised to $140 million - $150 million[19] Operational Metrics - Total clinicians reached 7,708, an 11% year-over-year growth, with 173 net clinician additions in Q2[9, 8] - Q2 2025 visit volumes increased by 12% year-over-year to 2.2 million[9] - The company operates over 550 centers in 33 states[8] Balance Sheet and Capital Allocation - Cash and cash equivalents totaled $189 million[17] - Net long-term debt is $273 million[17]

Financial Performance - Q1 2025 revenue reached $333.0 million, an 11% year-over-year increase[10] - Q1 2025 Center Margin was $109.8 million, representing 33.0% of revenue[10] - Q1 2025 Adjusted EBITDA was $34.6 million, or 10.4% of revenue[10] - The company ended Q1 2025 with a cash position of $134.3 million[10] Operational Metrics - Total clinicians reached 7,535, a 10% year-over-year increase, with 152 net clinician additions in Q1[10] - Q1 2025 visit volumes totaled 2.1 million, a 10% year-over-year increase[10] - The company operates over 550 centers in 33 states[8] Future Outlook - The company reaffirmed its FY 2025 revenue guidance of $1.40 billion to $1.44 billion[20] - The company reaffirmed its FY 2025 Adjusted EBITDA guidance of $130 million to $150 million[20] - The company anticipates opening 25 to 30 de novo centers in 2025[23]